Product Information

VERAPAMIL ER 120 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $3.0441 per EA under NDC 00378632001. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Apr 20, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL ER 120 MG CAPSULE

verapamil hydrochloride
$3.0441per EA

Strength

120 mg/1

NDC

00378632001

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075138

FDA Approved

4/20/1999

TE Code

AB

On Market Since

5/20/1999

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL ER 120 MG CAPSULE has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 488.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.0441 per EA
All-time high$3.0441 (Nov 18, 2026)
All-time low$0.4260 (Aug 20, 2014)
52-week high$3.0441
52-week low$1.2959
Median price$1.1414
Average price$1.1097
Largest weekly change+54.7% (May 20, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+4.4%

1M

+4.4%

3M

+30.6%

6M

+134.9%

1Y

+111.3%

3Y

+170.3%

5Y

+185.4%

All

+488.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VERAPAMIL ER 120 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 120 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $3.0441 per EA (NDC 00378632001), effective Nov 18, 2026.

How has the price of VERAPAMIL ER 120 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for VERAPAMIL ER 120 MG CAPSULE has risen 488.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 120 MG CAPSULE?

Since Nov 28, 2013, the NADAC for VERAPAMIL ER 120 MG CAPSULE has ranged from a low of $0.4260 (Aug 20, 2014) to a high of $3.0441 (Nov 18, 2026), with a median of $1.1414 per EA.

Are there cheaper alternatives to VERAPAMIL ER 120 MG CAPSULE?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL SR 120 MG CAPSULE, is $2.7493 per EA — about 10% below VERAPAMIL ER 120 MG CAPSULE.

Who manufactures VERAPAMIL ER 120 MG CAPSULE?

VERAPAMIL ER 120 MG CAPSULE (NDC 00378632001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.